A Pilot Phase II Study of the Efficacy and Biosafety of Doxorubicin Chemotherapy in Tumor-Bearing Equidae

Author:

Théon A.P.1,Pusterla N.2,Magdesian K.G.2,Wittenburg L.3,Marmulak T.2,Wilson W.D.2

Affiliation:

1. Department of Surgery and Radiology; School of Veterinary Medicine; University of California; Davis CA

2. Department of Medicine and Epidemiology ; School of Veterinary Medicine; University of California; Davis CA

3. Department of Clinical Sciences; Veterinary Medical Center; Pharmacology Core Facility; Colorado State University; Fort Collins CO

Funder

Cunningham and Doyle Charitable Trust Fund

UC Davis Center for Equine Health

Publisher

Wiley

Subject

General Veterinary

Reference26 articles.

1. Phase II evaluation of doxorubicin for treatment of various canine neoplasms;Ogilvie;J Am Vet Med Assoc,1989

2. Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats;Mauldin;J Vet Intern Med,1988

3. ECVIM-CA Preventing occupational and environmental exposure to cytotoxic drugs in veterinary medicine, 2nd ed http://www.ecvim-ca.org/guidelines 2007

4. Evaluation of the effects of dietary n-3 fatty acid supplementation on the pharmacokinetics of doxorubicin in dogs with lymphoma;Selting;Am J Vet Res,2006

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3